Sign In
Buy MRK
$120.78
+1.69 (+1.41%)
At Close: Jun 11, 2026
Farther Finance Advisors LLC Raises Holdings in Merck & Co., Inc. $MRK
06:14am, Thursday, 16'th Apr 2026
Farther Finance Advisors LLC boosted its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 48.9% during the undefined quarter, according to the company in its most recent Form 13F filing with t
1Q26 Earnings: Where Street Estimates Are Too Low And Who Should Beat
12:54pm, Wednesday, 15'th Apr 2026
Merck (MRK) is rated Very Attractive due to strong economic earnings, 20% ROIC, and undervaluation at $120/share. GAAP and Street Earnings understate MRK's profitability; Core Earnings provide a super
Will Keytruda Continue to Aid Merck's Top Line in Q1 Earnings?
09:45am, Wednesday, 15'th Apr 2026
MRK's Keytruda, driving over half of its pharma sales, remains in focus as Q1 nears, with growth expected from new indications and strong uptake.
Bingham Private Wealth LLC Makes New Investment in Merck & Co., Inc. $MRK
03:31am, Wednesday, 15'th Apr 2026
Bingham Private Wealth LLC bought a new position in Merck and Co., Inc. (NYSE: MRK) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fu
MRK, Daiichi's BLA for ADC Drug Gets FDA Priority Tag in Lung Cancer
01:20pm, Tuesday, 14'th Apr 2026
The FDA grants priority review to Merck and Daiichi's BLA for ifinatamab deruxtecan to treat extensive-stage small cell lung cancer.
Merck (MRK) Stock Sinks As Market Gains: Here's Why
06:51pm, Monday, 13'th Apr 2026
In the latest trading session, Merck (MRK) closed at $120.15, marking a -1.05% move from the previous day.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--I-DXd BLA Acceptance.
Trump policies, China's biotech boom are ending Europe's pharma powerhouse era
01:54am, Saturday, 11'th Apr 2026
Once the go-to location for global drugmakers, Europe is losing market share to aggressive U.S. trade policies and China's growth as a biotech hub. Europe's share of global R&D has been cut in half ov
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of T
1Q26 Earnings: Where Street Estimates Are Too Low & Who Should Beat
02:20pm, Friday, 10'th Apr 2026
GAAP earnings, despite popular opinion, don't accurately measure profits. Companies can, and do, manipulate GAAP earnings through accounting rule loopholes.
BOCHK Asset Management Ltd Invests $1.90 Million in Merck & Co., Inc. $MRK
05:30am, Friday, 10'th Apr 2026
BOCHK Asset Management Ltd purchased a new position in Merck and Co., Inc. (NYSE: MRK) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exch
Cardinal Capital Management Inc. Has $32.06 Million Stock Holdings in Merck & Co., Inc. $MRK
04:56am, Friday, 10'th Apr 2026
Cardinal Capital Management Inc. raised its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 3.6% in the undefined quarter, according to its most recent 13F filing with the Securities and Exch
AZN vs. MRK: Which Oncology Stock Offers Better Investment Potential?
10:21am, Thursday, 09'th Apr 2026
Though both dominate oncology, a stronger growth outlook and clearer targets may give AstraZeneca an edge over Merck.
Franklin Street Advisors Inc. NC Grows Position in Merck & Co., Inc. $MRK
04:59am, Thursday, 09'th Apr 2026
Franklin Street Advisors Inc. NC lifted its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 462.8% in the undefined quarter, according to the company in its most recent 13F filing with the Se
Merck (MRK) Stock Declines While Market Improves: Some Information for Investors
06:51pm, Tuesday, 07'th Apr 2026
The latest trading day saw Merck (MRK) settling at $119.28, representing a -1.3% change from its previous close.
